An erythroid-biased FOShi hematopoietic multipotent progenitor subpopulation contributes to adaptation to chronic hypoxia

Cell Stem Cell. 2025 Jun 5;32(6):935-951.e7. doi: 10.1016/j.stem.2025.03.010. Epub 2025 Apr 11.

Abstract

Hypoxia imposes notable stress on organisms and even causes tissue damage; however, the cellular and molecular mechanisms underlying hypoxic adaptation and maladaptation are elusive. Here, we performed single-cell RNA sequencing to analyze hematopoietic stem and progenitor cells (HSPCs) and erythroid cells in a mouse model of high-altitude polycythemia (HAPC) mimicking long-term high-altitude hypoxia exposure. We identified a distinct erythroid-biased multipotent progenitor subset, FOShi MPP, characterized by a unique responsiveness to interferon (IFN) signaling, which expands under hypoxia conditions. This subset rapidly responds to hypoxia during re-ascent by sustaining low methylation of erythroid-priming genes, suggesting a memory function in HSPCs for faster acclimatization. Additionally, erythroid cells in HAPC mice had active metabolic and autophagic activity, as well as abundant CD47 expression that prevented the phagocytosis of erythrocytes. Finally, CD47 blockade and/or IFNα treatments alleviated erythrocytosis in HAPC mice. These approaches might constitute promising therapeutic strategies for HAPC.

Keywords: CD47; IFNα; hematopoietic stem and progenitor cells; high-altitude polycythemia; scRNA-seq.

MeSH terms

  • Adaptation, Physiological*
  • Animals
  • CD47 Antigen / metabolism
  • Chronic Disease
  • Erythroid Cells* / metabolism
  • Hematopoietic Stem Cells* / metabolism
  • Hypoxia* / metabolism
  • Hypoxia* / pathology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Multipotent Stem Cells* / metabolism
  • Polycythemia / pathology

Substances

  • CD47 Antigen